References
| Author (yr) | Title | Citation | Isolate |
|---|---|---|---|
| Qi (2013) | HIV-1 diversity, drug-resistant mutations, and viral evolution among high-risk individuals in phase II HIV vaccine trial sites in southern China. | PLoS ONE | PR HIV1 group M: 65 RT HIV1 group M: 65 |